
LINK . SPRINGER . COM {
}
Title:
A Legumain-based minigene vaccine targets the tumor stroma and suppresses breast cancer growth and angiogenesis | Cancer Immunology, Immunotherapy
Description:
Tumor associated macrophages (TAMs) are well known to play a very important role in tumor angiogenesis and metastasis. The suppression of TAMs in the tumor-microenvironment (TME) provides a novel strategy to inhibit tumor growth and dissemination by remodeling the tumor’s stroma. Here, we tested our hypothesis that suppression of TAMs can be achieved in syngeneic BALB/c mice with oral minigene vaccines against murine MHC class I antigen epitopes of Legumain, an asparaginyl endopeptidase and a member of the C13 family of cystine proteases which is overexpressed on TAMs in the tumor stroma. Vaccine vectors were constructed and transformed into attenuated Salmonella typhimurium (Dam − , AroA − ) for oral delivery. Groups of mice received either the expression vectors encoding the Legumain H-2D or 2K epitopes or the control empty vector by gavage. The efficacy of the minigene vaccines was determined by their ability to protect mice from lethal tumor cell challenges, the induction of a specific CTL response as well as IFN-γ release, and inhibition of tumor angiogenesis. We demonstrated that the Legumain minigene vaccine provided effective protection against tumor cell challenge by inducing a specific CD8+ T-cell response against Legumain+ TAMs in our breast tumor model. The protection, induced by this T-cell response, mediated by the Legumain Kd minigene, is also responsible for lysing D2F2 breast carcinoma cells in syngeneic BALB/c mice and for suppressing tumor angiogenesis. Importantly, in a prophylactic setting, the minigene vaccine proved to be of similar anti-tumor efficacy as a vaccine encoding the entire Legumain gene. Together, our findings establish proof of concept that a Legumain minigene vaccine provides a more flexible alternative to the whole gene vaccine, which may facilitate the future design and clinical applications of such a vaccine for cancer prevention.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Education
- Science
- Politics
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 7,626,432 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
The income method remains a mystery to us.
While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Link.springer.com might be earning cash quietly, but we haven't detected the monetization method.
Keywords {🔍}
article, tumor, cancer, pubmed, cas, google, scholar, vaccine, xiang, minigene, reisfeld, legumain, mizutani, zhou, luo, vaccines, research, breast, angiogenesis, macrophages, tams, antigen, access, dna, privacy, cookies, content, van, usa, publish, search, immunotherapy, stroma, growth, rong, mice, cell, tcell, clin, res, data, protection, information, log, journal, immunology, september, lewēn, markowitz, yunping,
Topics {✒️}
t-cell immunotherapy revives oral minigene vaccines darmstadt-lexigen research center t-cell-mediated suppression myeloid-derived suppressor cells month download article/chapter t-cell response tingmei cheng & rong xiang minigene vaccines similar anti-tumor efficacy tumor cell challenge article cancer immunology immunosuppressive tumor microenvironment full article pdf macrophage activation switching immunotherapy article privacy choices/manage cookies breast cancer vaccine legumain minigene vaccine minigene vaccine proved specific ctl response related subjects legumain kd minigene check access instant access scripps research institute scripps research institute breast tumor model manuscript number 17696-imm inhibit tumor growth inhibits tumor growth dna vaccine huai-dong hu established metastatic disease tumor-microenvironment colon cancer model suppressing tumor angiogenesis tumor protective immunity legumain h-2d murine mhc class article lewēn yunping luo european economic area syngeneic balb/ attenuated salmonella typhimurium control empty vector ifn-γ release findings establish proof adaptive antitumor immunity transgenic mouse model
Schema {🗺️}
WebPage:
mainEntity:
headline:A Legumain-based minigene vaccine targets the tumor stroma and suppresses breast cancer growth and angiogenesis
description:Tumor associated macrophages (TAMs) are well known to play a very important role in tumor angiogenesis and metastasis. The suppression of TAMs in the tumor-microenvironment (TME) provides a novel strategy to inhibit tumor growth and dissemination by remodeling the tumor’s stroma. Here, we tested our hypothesis that suppression of TAMs can be achieved in syngeneic BALB/c mice with oral minigene vaccines against murine MHC class I antigen epitopes of Legumain, an asparaginyl endopeptidase and a member of the C13 family of cystine proteases which is overexpressed on TAMs in the tumor stroma. Vaccine vectors were constructed and transformed into attenuated Salmonella typhimurium (Dam
−
, AroA
−
) for oral delivery. Groups of mice received either the expression vectors encoding the Legumain H-2D or 2K epitopes or the control empty vector by gavage. The efficacy of the minigene vaccines was determined by their ability to protect mice from lethal tumor cell challenges, the induction of a specific CTL response as well as IFN-γ release, and inhibition of tumor angiogenesis. We demonstrated that the Legumain minigene vaccine provided effective protection against tumor cell challenge by inducing a specific CD8+ T-cell response against Legumain+ TAMs in our breast tumor model. The protection, induced by this T-cell response, mediated by the Legumain Kd minigene, is also responsible for lysing D2F2 breast carcinoma cells in syngeneic BALB/c mice and for suppressing tumor angiogenesis. Importantly, in a prophylactic setting, the minigene vaccine proved to be of similar anti-tumor efficacy as a vaccine encoding the entire Legumain gene. Together, our findings establish proof of concept that a Legumain minigene vaccine provides a more flexible alternative to the whole gene vaccine, which may facilitate the future design and clinical applications of such a vaccine for cancer prevention.
datePublished:2007-09-05T00:00:00Z
dateModified:2007-09-05T00:00:00Z
pageStart:507
pageEnd:515
sameAs:https://doi.org/10.1007/s00262-007-0389-x
keywords:
Legumain
Minigene vaccine
Tumor associated macrophages
Anti-angiogenesis
CTLs
Oncology
Immunology
Cancer Research
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-007-0389-x/MediaObjects/262_2007_389_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-007-0389-x/MediaObjects/262_2007_389_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-007-0389-x/MediaObjects/262_2007_389_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-007-0389-x/MediaObjects/262_2007_389_Fig4_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-007-0389-x/MediaObjects/262_2007_389_Fig5_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-007-0389-x/MediaObjects/262_2007_389_Fig6_HTML.gif
isPartOf:
name:Cancer Immunology, Immunotherapy
issn:
1432-0851
0340-7004
volumeNumber:57
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Susanna Lewēn
affiliation:
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
type:Organization
type:Person
name:He Zhou
affiliation:
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
type:Organization
type:Person
name:Huai-dong Hu
affiliation:
name:Chongqing Medical University
address:
name:Key Laboratory of Molecular Biology for Infectious Disease, Ministry of Education, Institute for Viral Hepatitis, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
type:PostalAddress
type:Organization
type:Person
name:Tingmei Cheng
affiliation:
name:Chongqing Medical University
address:
name:Key Laboratory of Molecular Biology for Infectious Disease, Ministry of Education, Institute for Viral Hepatitis, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
type:PostalAddress
type:Organization
type:Person
name:Dorothy Markowitz
affiliation:
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
type:Organization
type:Person
name:Ralph A. Reisfeld
affiliation:
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
type:Organization
type:Person
name:Rong Xiang
affiliation:
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
type:Organization
name:Chongqing Medical University
address:
name:Key Laboratory of Molecular Biology for Infectious Disease, Ministry of Education, Institute for Viral Hepatitis, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Yunping Luo
affiliation:
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:A Legumain-based minigene vaccine targets the tumor stroma and suppresses breast cancer growth and angiogenesis
description:Tumor associated macrophages (TAMs) are well known to play a very important role in tumor angiogenesis and metastasis. The suppression of TAMs in the tumor-microenvironment (TME) provides a novel strategy to inhibit tumor growth and dissemination by remodeling the tumor’s stroma. Here, we tested our hypothesis that suppression of TAMs can be achieved in syngeneic BALB/c mice with oral minigene vaccines against murine MHC class I antigen epitopes of Legumain, an asparaginyl endopeptidase and a member of the C13 family of cystine proteases which is overexpressed on TAMs in the tumor stroma. Vaccine vectors were constructed and transformed into attenuated Salmonella typhimurium (Dam
−
, AroA
−
) for oral delivery. Groups of mice received either the expression vectors encoding the Legumain H-2D or 2K epitopes or the control empty vector by gavage. The efficacy of the minigene vaccines was determined by their ability to protect mice from lethal tumor cell challenges, the induction of a specific CTL response as well as IFN-γ release, and inhibition of tumor angiogenesis. We demonstrated that the Legumain minigene vaccine provided effective protection against tumor cell challenge by inducing a specific CD8+ T-cell response against Legumain+ TAMs in our breast tumor model. The protection, induced by this T-cell response, mediated by the Legumain Kd minigene, is also responsible for lysing D2F2 breast carcinoma cells in syngeneic BALB/c mice and for suppressing tumor angiogenesis. Importantly, in a prophylactic setting, the minigene vaccine proved to be of similar anti-tumor efficacy as a vaccine encoding the entire Legumain gene. Together, our findings establish proof of concept that a Legumain minigene vaccine provides a more flexible alternative to the whole gene vaccine, which may facilitate the future design and clinical applications of such a vaccine for cancer prevention.
datePublished:2007-09-05T00:00:00Z
dateModified:2007-09-05T00:00:00Z
pageStart:507
pageEnd:515
sameAs:https://doi.org/10.1007/s00262-007-0389-x
keywords:
Legumain
Minigene vaccine
Tumor associated macrophages
Anti-angiogenesis
CTLs
Oncology
Immunology
Cancer Research
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-007-0389-x/MediaObjects/262_2007_389_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-007-0389-x/MediaObjects/262_2007_389_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-007-0389-x/MediaObjects/262_2007_389_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-007-0389-x/MediaObjects/262_2007_389_Fig4_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-007-0389-x/MediaObjects/262_2007_389_Fig5_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-007-0389-x/MediaObjects/262_2007_389_Fig6_HTML.gif
isPartOf:
name:Cancer Immunology, Immunotherapy
issn:
1432-0851
0340-7004
volumeNumber:57
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Susanna Lewēn
affiliation:
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
type:Organization
type:Person
name:He Zhou
affiliation:
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
type:Organization
type:Person
name:Huai-dong Hu
affiliation:
name:Chongqing Medical University
address:
name:Key Laboratory of Molecular Biology for Infectious Disease, Ministry of Education, Institute for Viral Hepatitis, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
type:PostalAddress
type:Organization
type:Person
name:Tingmei Cheng
affiliation:
name:Chongqing Medical University
address:
name:Key Laboratory of Molecular Biology for Infectious Disease, Ministry of Education, Institute for Viral Hepatitis, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
type:PostalAddress
type:Organization
type:Person
name:Dorothy Markowitz
affiliation:
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
type:Organization
type:Person
name:Ralph A. Reisfeld
affiliation:
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
type:Organization
type:Person
name:Rong Xiang
affiliation:
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
type:Organization
name:Chongqing Medical University
address:
name:Key Laboratory of Molecular Biology for Infectious Disease, Ministry of Education, Institute for Viral Hepatitis, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Yunping Luo
affiliation:
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Cancer Immunology, Immunotherapy
issn:
1432-0851
0340-7004
volumeNumber:57
Organization:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
name:Chongqing Medical University
address:
name:Key Laboratory of Molecular Biology for Infectious Disease, Ministry of Education, Institute for Viral Hepatitis, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
type:PostalAddress
name:Chongqing Medical University
address:
name:Key Laboratory of Molecular Biology for Infectious Disease, Ministry of Education, Institute for Viral Hepatitis, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
type:PostalAddress
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
name:Chongqing Medical University
address:
name:Key Laboratory of Molecular Biology for Infectious Disease, Ministry of Education, Institute for Viral Hepatitis, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
type:PostalAddress
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Susanna Lewēn
affiliation:
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
type:Organization
name:He Zhou
affiliation:
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
type:Organization
name:Huai-dong Hu
affiliation:
name:Chongqing Medical University
address:
name:Key Laboratory of Molecular Biology for Infectious Disease, Ministry of Education, Institute for Viral Hepatitis, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
type:PostalAddress
type:Organization
name:Tingmei Cheng
affiliation:
name:Chongqing Medical University
address:
name:Key Laboratory of Molecular Biology for Infectious Disease, Ministry of Education, Institute for Viral Hepatitis, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
type:PostalAddress
type:Organization
name:Dorothy Markowitz
affiliation:
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
type:Organization
name:Ralph A. Reisfeld
affiliation:
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
type:Organization
name:Rong Xiang
affiliation:
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
type:Organization
name:Chongqing Medical University
address:
name:Key Laboratory of Molecular Biology for Infectious Disease, Ministry of Education, Institute for Viral Hepatitis, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
type:PostalAddress
type:Organization
email:[email protected]
name:Yunping Luo
affiliation:
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
name:Key Laboratory of Molecular Biology for Infectious Disease, Ministry of Education, Institute for Viral Hepatitis, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
name:Key Laboratory of Molecular Biology for Infectious Disease, Ministry of Education, Institute for Viral Hepatitis, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
name:Key Laboratory of Molecular Biology for Infectious Disease, Ministry of Education, Institute for Viral Hepatitis, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {🔗}(85)
- How much does https://www.springernature.com/gp/authors net monthly?
- What's https://link.springernature.com/home/'s gross income?
- What is the earnings of https://order.springer.com/public/cart?
- How much does https://submission.nature.com/new-submission/262/3 earn?
- Learn about the earnings of https://www.springernature.com/gp/librarians/licensing/agc/journals
- Income figures for https://doi.org/10.1172%2FJCI27648
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16862213
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Targeting%20tumor-associated%20macrophages%20as%20a%20novel%20strategy%20against%20breast%20cancer&journal=J%20Clin%20Invest&doi=10.1172%2FJCI27648&volume=116&publication_year=2006&author=Luo%2CY&author=Zhou%2CH&author=Krueger%2CJ&author=Kaplan%2CC&author=Lee%2CSH&author=Dolman%2CC&author=Markowitz%2CD&author=Wu%2CW&author=Liu%2CC&author=Reisfeld%2CRA&author=Xiang%2CR
- What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12782603?
- How much money does http://scholar.google.com/scholar_lookup?&title=Overexpression%20of%20legumain%20in%20tumors%20is%20significant%20for%20invasion%2Fmetastasis%20and%20a%20candidate%20enzymatic%20target%20for%20prodrug%20therapy&journal=Cancer%20Res&volume=63&publication_year=2003&author=Liu%2CC&author=Sun%2CC&author=Huang%2CH&author=Janda%2CK&author=Edgington%2CT make?
- How much revenue does https://doi.org/10.1158%2F1078-0432.CCR-04-1642 produce monthly?
- Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15788679
- http://scholar.google.com/scholar_lookup?&title=Legumain%20expression%20in%20relation%20to%20clinicopathologic%20and%20biological%20variables%20in%20colorectal%20cancer&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-04-1642&volume=11&publication_year=2005&author=Murthy%2CRV&author=Arbman%2CG&author=Gao%2CJ&author=Roodman%2CGD&author=Sun%2CXF's total income per month
- What are the earnings of https://doi.org/10.1182%2Fblood-2005-03-0969?
- Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15920006
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=T-cell-mediated%20suppression%20of%20angiogenesis%20results%20in%20tumor%20protective%20immunity&journal=Blood&doi=10.1182%2Fblood-2005-03-0969&volume=106&publication_year=2005&author=Zhou%2CH&author=Luo%2CY&author=Mizutani%2CM&author=Mizutani%2CN&author=Xiang%2CR&author=Reisfeld%2CRA
- What is the earnings of https://doi.org/10.1073%2Fpnas.090097697?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10779556 bring in each month?
- Monthly income for http://scholar.google.com/scholar_lookup?&title=An%20autologous%20oral%20DNA%20vaccine%20protects%20against%20murine%20melanoma&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.090097697&volume=97&publication_year=2000&author=Xiang%2CR&author=Lode%2CHN&author=Chao%2CTH&author=Ruehlmann%2CJM&author=Dolman%2CCS&author=Rodriguez%2CF&author=Whitton%2CJL&author=Overwijk%2CWW&author=Restifo%2CNP&author=Reisfeld%2CRA
- How much does https://doi.org/10.1073%2Fpnas.1033132100 pull in monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12857959 pull in?
- How much does http://scholar.google.com/scholar_lookup?&title=Transcription%20factor%20Fos-related%20antigen%201%20is%20an%20effective%20target%20for%20a%20breast%20cancer%20vaccine&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.1033132100&volume=100&publication_year=2003&author=Luo%2CY&author=Zhou%2CH&author=Mizutani%2CM&author=Mizutani%2CN&author=Reisfeld%2CRA&author=Xiang%2CR rake in every month?
- Learn about the earnings of https://doi.org/10.1158%2F0008-5472.CAN-05-1132
- How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15833877 earning monthly?
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=A%20DNA%20vaccine%20targeting%20Fos-related%20antigen%201%20enhanced%20by%20IL-18%20induces%20long-lived%20T-cell%20memory%20against%20tumor%20recurrence&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-05-1132&volume=65&publication_year=2005&author=Luo%2CY&author=Zhou%2CH&author=Mizutani%2CM&author=Mizutani%2CN&author=Liu%2CC&author=Xiang%2CR&author=Reisfeld%2CRA?
- Get to know what's the income of https://doi.org/10.1073%2Fpnas.0502208102
- How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16040807 earning monthly?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=DNA-based%20vaccines%20activate%20innate%20and%20adaptive%20antitumor%20immunity%20by%20engaging%20the%20NKG2D%20receptor&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.0502208102&volume=102&publication_year=2005&author=Zhou%2CH&author=Luo%2CY&author=Lo%2CJF&author=Kaplan%2CCD&author=Mizutani%2CM&author=Mizutani%2CN&author=Lee%2CJD&author=Primus%2CFJ&author=Becker%2CJC&author=Xiang%2CR&author=Reisfeld%2CRA generate?
- What's the financial outcome of https://doi.org/10.1172%2FJCI200421107?
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15199414 earns monthly
- How much does http://scholar.google.com/scholar_lookup?&title=A%20novel%20transgenic%20mouse%20model%20for%20immunological%20evaluation%20of%20carcinoembryonic%20antigen-based%20DNA%20minigene%20vaccines&journal=J%20Clin%20Invest&doi=10.1172%2FJCI200421107&volume=113&publication_year=2004&author=Zhou%2CH&author=Luo%2CY&author=Mizutani%2CM&author=Mizutani%2CN&author=Becker%2CJC&author=Primus%2CFJ&author=Xiang%2CR&author=Reisfeld%2CRA make?
- How much does https://doi.org/10.1038%2Fnm794 make?
- How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12415261?
- How much does http://scholar.google.com/scholar_lookup?&title=A%20DNA%20vaccine%20against%20VEGF%20receptor%202%20prevents%20effective%20angiogenesis%20and%20inhibits%20tumor%20growth&journal=Nat%20Med&doi=10.1038%2Fnm794&volume=8&publication_year=2002&author=Niethammer%2CAG&author=Xiang%2CR&author=Becker%2CJC&author=Wodrich%2CH&author=Pertl%2CU&author=Karsten%2CG&author=Eliceiri%2CBP&author=Reisfeld%2CRA rake in every month?
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15634881
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Reduction%20of%20myeloid-derived%20suppressor%20cells%20and%20induction%20of%20M1%20macrophages%20facilitate%20the%20rejection%20of%20established%20metastatic%20disease&journal=J%20Immunol&volume=174&publication_year=2005&author=Sinha%2CP&author=Clements%2CVK&author=Ostrand-Rosenberg%2CS generate?
- What's the revenue for https://doi.org/10.1084%2Fjem.176.1.287?
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1613462?
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Interleukin%204%20potently%20enhances%20murine%20macrophage%20mannose%20receptor%20activity%3A%20a%20marker%20of%20alternative%20immunologic%20macrophage%20activation&journal=J%20Exp%20Med&doi=10.1084%2Fjem.176.1.287&volume=176&publication_year=1992&author=Stein%2CM&author=Keshav%2CS&author=Harris%2CN&author=Gordon%2CS?
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16297160's gross income?
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Macrophage%20activation%20switching%3A%20an%20asset%20for%20the%20resolution%20of%20inflammation&journal=Clin%20Exp%20Immunol&volume=142&publication_year=2005&author=Porcheray%2CF&author=Viaud%2CS&author=Rimaniol%2CAC&author=Leone%2CC&author=Samah%2CB&author=reuddre-Bosquet%2CN&author=Dormont%2CD&author=Gras%2CG
- What's the financial intake of https://doi.org/10.1016%2FS1357-4310%2899%2901451-3?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10203751's revenue stream
- How much does http://scholar.google.com/scholar_lookup?&title=HLA%20class%20I%20antigen%20downregulation%20in%20human%20cancers%3A%20T-cell%20immunotherapy%20revives%20an%20old%20story&journal=Mol%20Med%20Today&doi=10.1016%2FS1357-4310%2899%2901451-3&volume=5&publication_year=1999&author=Hicklin%2CDJ&author=Marincola%2CFM&author=Ferrone%2CS earn?
- How much revenue does https://doi.org/10.1038%2Fsj.onc.1200917 generate?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9050997 generate monthly?
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Small%20polydispersed%20circular%20DNA%20%28spcDNA%29%20in%20human%20cells%3A%20association%20with%20genomic%20instability&journal=Oncogene&doi=10.1038%2Fsj.onc.1200917&volume=14&publication_year=1997&author=Cohen%2CS&author=Regev%2CA&author=Lavi%2CS?
- Income figures for https://doi.org/10.1038%2F37126
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9389480 earn?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Antiangiogenic%20therapy%20of%20experimental%20cancer%20does%20not%20induce%20acquired%20drug%20resistance&journal=Nature&doi=10.1038%2F37126&volume=390&publication_year=1997&author=Boehm%2CT&author=Folkman%2CJ&author=Browder%2CT&author=O%E2%80%99Reilly%2CMS?
- What are the earnings of https://citation-needed.springer.com/v2/references/10.1007/s00262-007-0389-x?format=refman&flavour=references?
- Financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Susanna%20Lew%C4%93n
- Get to know https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Susanna%20Lew%C4%93n%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's earnings
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=He%20Zhou generate monthly?
- Financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22He%20Zhou%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What's the profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Huai-dong%20Hu?
- How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Huai-dong%20Hu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Tingmei%20Cheng pull in?
- What's the financial outcome of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Tingmei%20Cheng%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the total monthly financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Dorothy%20Markowitz?
- What's the revenue for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Dorothy%20Markowitz%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ralph%20A.%20Reisfeld's revenue stream
- Learn about the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ralph%20A.%20Reisfeld%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What are the total earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Rong%20Xiang?
- Income figures for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Rong%20Xiang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What's the financial outcome of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yunping%20Luo?
- What's the revenue for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yunping%20Luo%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Earnings of https://s100.copyright.com/AppDispatchServlet?title=A%20Legumain-based%20minigene%20vaccine%20targets%20the%20tumor%20stroma%20and%20suppresses%20breast%20cancer%20growth%20and%20angiogenesis&author=Susanna%20Lew%C4%93n%20et%20al&contentID=10.1007%2Fs00262-007-0389-x©right=Springer-Verlag&publication=0340-7004&publicationDate=2007-09-05&publisherName=SpringerNature&orderBeanReset=true
- How much does https://citation-needed.springer.com/v2/references/10.1007/s00262-007-0389-x?format=refman&flavour=citation net monthly?
- How much revenue does https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral generate?
- How much does https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research pull in?
- Get to know https://www.springernature.com/gp/products's earnings
- How much revenue does https://www.springernature.com/gp/librarians generate?
- Revenue of https://www.springernature.com/gp/societies
- Learn how profitable https://www.springernature.com/gp/partners is on a monthly basis
- What's the income of https://www.springer.com/?
- Earnings of https://www.nature.com/
- How much profit does https://www.biomedcentral.com/ generate?
- How much cash flow does https://www.palgrave.com/ have monthly?
- What are the earnings of https://www.apress.com/?
- What's the revenue for https://www.springernature.com/gp/legal/ccpa?
- See how much https://www.springernature.com/gp/info/accessibility makes per month
- Check the income stats for https://support.springernature.com/en/support/home
- Check the income stats for https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations
- What's the profit of https://www.springernature.com/?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref